Methods of administering gaultherin-containing compositions

Details Methods of administering gaultherin-containing compositions Methods of administering gaultherin-containing compositions

2006-04-25

2006-04-25

Meller, Michael (Department: 1654)

Drug, bio-affecting and body treating compositions

Plant material or plant extract of undetermined constitution...

Reexamination Certificate

active

07033618

ABSTRACT:
The present disclosure provides methods for obtaining gaultherin, a natural salicylate derivative, from plant tissue. The methods involve preventing the hydrolysis of the gaultherin in the plant tissue by disrupting the plant tissue under solvent conditions lacking a drying agent. The disclosure further provides various forms of plant-derived gaultherin, including alcoholic extracts, aqueous solutions and dried preparations, all suitable for use as a natural aspirin substitute. Moreover, the disclosure provides methods of using gaultherin-containing compositions to increase serum salicylic acid, to treat cancer cells, to treat cardiovascular (e.g., cardiopulmonary) conditions, to treat anti-inflammatory responses, and to inhibit cyclooxygenase.

REFERENCES:
patent: 3615702 (1971-10-01), Swisher
patent: 3954978 (1976-05-01), Magolan
patent: 4021439 (1977-05-01), Krenzer
patent: 5176913 (1993-01-01), Honerlagen et al.
patent: 5294434 (1994-03-01), King et al.
patent: 5592956 (1997-01-01), Ju et al.
patent: 5633027 (1997-05-01), Cherukuri et al.
patent: 5698181 (1997-12-01), Luo
patent: 2002/0031562 (2002-03-01), Ribnicky et al.
Balick et al., “Plants, People, and Culture,”Scientific American Library, New York, p. 32 (1997).
Barnaulov et al.,. “Chemical Composition and Initial Assessment of Pharmacologic Properties of Preparations Made ofFilipendula Ulmaria(L)MaximFlowers” (Translated),Rastit. Resur., 13(4): 661-669 (1977).
Barnett et al., eds. “Acetylsalicylic Acid, New Uses for an Old Drug,” Raven Press, New York (1982) (Table of Contents only).
Bishop, “Botanicals in Bath Care, Herbal extracts and Aromatic Essential Oils Have Been Used for Centuries to Yield Benefits Now Sought by Society,”Cosmetics&Toiletries, 104:65-69 (1989).
Bridel et al., “Etude biochimique sur la composition du Monotropa Hypopitys L. Obtention d'un nouveau glucoside à salicylate de méthyle, la monotropitine,”Comptes Rendus, pp. 642-644 (1923).
Bridel et al., “Sur l'hydrolyse fermentaire de la monotropitine. Obtention du primevérose,”Comptes Rendus, pp. 991-993 (1924).
Bridel et al., “Sur un complexe glucosidique instable de l'écorce de tige de Nerprun purgative (Rhamnus cathartica L.),”Comptes Rendus, pp. 857-860 (1925).
Bridel et al., “Le primevérose, les primevérosides et la primevérosidase,”ComptesRendus, 1421-1423 (1925).
Bridel et al., “Sur la préparation et les propriétés du monotropitoside,”Comptes Rendus, pp. 1864-1866 (1925).
Bridel et al., “Le glucoside á salicylate de méthyle du Gaultheria procumbens L. ést le monotropitoside,”Comptes Rendus, pp. 609-611 (1928).
Butler et al., “Prolongation of Rat Tail Bleeding Time Cause by Oral Doses of a Thromboxane Synthetase Inhibitor Which Have Little Effect on Platelet Aggregation,”Thrombosis Hemostasis, 47:46-49 (1982).
Cohen et al., “13C6-[Benzene Ring]-Indole-3-Acetic Acid, A New Internal Standard for Quantitative Mass Spectral Analysis of Indole-3-Acetic Acid in Plants,”Plant Physiol., 80:14-19 (1986).
Dejana et al., “Bleeding Time in Laboratory Animals II—A Comparison of Different Assay Conditions in Rats,”Thrombosis Research, 15:191-197 (1979).
Enyedi et al., “Localization, conjugation, and function of salicylic acid in tobacco during the hypersensitive reaction to tobacco mosaic virus,”Proc. Nat'l. Acad. Sci. (USA), 89:2480-2484 (1992).
Goris et al., “Caractères et composition du Primevérose,”Comptes Rendus, 871-873 (1919).
Guth et al., “Topical Aspirin Plus HCI Gastric Lesions in the Rat,”Gasrtoenterology, 76:88-93 (1979).
Kayser et al., “Local and remote modifications of nociceptive sensitivity during carrageenin-induced inflammation in the rat,”Pain, 28:99-107 (1987).
Miller et al., “Reporting Results of Cancer Treatment,”Cancer, 47(1):207-214 (1981).
Nunez et al., “Specific Inhibition of PAF-Acether-Induced Platelet Activation By BN 52021 And Comparison With The PAF-Acether Inhibitors Kadsurenone And CV 3988,”European Journal of Pharmacology, 123:197-205 (1986).
Onions, “Botanicals—Back to Basics Part 2,”Soap Perfumery&Cosmetics, 64(11):57-59 (1991).
Perry et al., “Health Effects of Salicylates in Foods and Drugs,”Nutrition Reviews, 54(8):225-240 (1996).
Pierpoint, “Salicylic Acid and its Derivatives in Plants: Medicines, Metabolites and Messenger Molecules, ”Advances in Botanical Research, 20:164-235 (1994).
Procter, Jr., “Observations on the Volatile Oil of Betula Lenta, and on Gaultherin, a Substance Which, by Its Decomposition, Yields that Oil,”The American Journal of Pharmacy, IX(IV), pp. 22, 242-250 (1844).
Raskin et al., “Salicylic Acid Levels in Thermogenic and Non-Thermogenic Plants,”Annals of Botany, 66:369-373 (1990).
Ren et al., “Inflammatory Models of Pain and Hyperalgesia,”ILAR Journal, 40(3):111-118 (1999).
Ribnicky et al., “Intermediates of Salicylic Acid Biosynthesis in Tobacco,”Plant Physiol., 118:565-572 (1998).
Ribnicky et al., “Determination of salicylates inGaultheria procumbensby LC-MS and GC-MS,” (Abstract) (Aug., 1999).
Ribnicky et al., Development of PMI-5001, a Natural Salicylate fromGaultheria procumbensfor Cardiovascular Health, (Abstract) (Jan., 2002).
Robertson et al., “Syntheses of Glucosides, Part VIII, The Synthesis of Monotropitoside (Gaultherin),”J. Amer. Chem. Soc., 1881-1888 (1931).
Scott et al., “Mass Spectrometic Quantification of Salicylic Acid in Plant Tissues,”Phytochemistry, 37(2):335-336 (1994).
Shimura et al., “Docosahexanoic Acid (DHA) Improved Glucose and Lipid Metabolism in KK-AyMice with Genetic Non-Insulin-Dependent Diabetes Mellitus (NIDDM),”Biol. Pharm. Bull., 20(5):507-510 (1997).
Towers et al., “Phenolic Acids and Phenolic Glycosides ofGaultheriaSpecies,”Phytochemistry, 5:677-681 (1966).
Tyler et al., eds. “Gaultheria Oil,”Pharmacognosy, 8thEdition, Lea & Febiger, Philadelphia, pp. 142-143 (1981),
Yeo et al., “Phytochemical Studies on the Constituents ofFilipendula glaberrima,” Korean Journal of Pharmacognosy, 23(3):121-125 (1992).
Zhang et al., “Gaultherins A and B, two lignans fromGaultheria yunnanensis,” Phytochemistry, 51:469-472 (1999).
International Search Report for PCT/US01/20008 dated Sep. 26, 2001.
Written Opinion for PCT/US01/20008 dated May 7, 2003.
International Search Report for PCT/US03/02502 dated May 5, 2003.

Affiliated with

Also associated with

Rating

Methods of administering gaultherin-containing compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of administering gaultherin-containing compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of administering gaultherin-containing compositions will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3582520